We'll be across London Life Sciences Week and the Jefferies London Healthcare Conference where we welcome discussions with investors with an interest in clinical stage AI and increasing healthspan, in addition to biopharma companies seeking to improve probability of R&D success and diagnostics companies advancing novel tools for complex, chronic diseases.
Arrange a meeting with our leadership team during London Life Sciences Week and the Jefferies London Healthcare Conference.
Predict, treat & prevent complex diseaseSpeak to us to learn how our AI-led precision medicine is maximizing success throughout drug discovery and development, increasing healthcare efficiency, and improving health outcomes. Healthcare & DiagnosticsWe're developing a pipeline of transformative diagnostics that assess disease risk, the specific mechanisms underpinning disease, and recommend treatments that are consistent with the mechanisms of action present in the patient. Drug DiscoveryWe de-risk target evaluation and selection with knowledge of causal genetic, mechanistic explanation of observed clinical phenotype, mechanistic prevalence, match to target product profile and secondary indications. Drug DevelopmentWe're improving probability of success through indication prioritization and mechanistic patient stratification biomarkers to design precision medicine clinical trials that are faster to readout and more likely to succeed. |
|
Recent news
|